Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • BIOCRYST PHARMACEUTICALS Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 61.53 M 50.70 M 37.46 M 50.26 M 23.17 M
    Net Receivables 11.98 M 39.13 M 4.56 M 30.00 M 0.00
    Total Inventories 0.00 0.00 0.00 0.00 0.00
    Progress Payments & Others 0.00 0.00 0.00 0.00 0.00
    Prepaid Expenses
    Other Current Assets 1.51 M 1.88 M 3.78 M 839,662.00 699,284.00
    Current Assets Total 75.02 M 91.70 M 45.79 M 81.10 M 23.87 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 1.79 M 34.31 M 8.78 M 9.73 M 5.53 M
    Property, Plant & Equipment Net 4.88 M 5.29 M 3.03 M 2.41 M 2.82 M
    Property, Plant & Equipment Gross 15.92 M 14.80 M 11.51 M 10.12 M 9.73 M
    Accumulated Depreciation 11.03 M 9.51 M 8.48 M 7.71 M 6.91 M
    Other Assets 3.00 M 11.41 M 10.89 M 6.01 M 248,586.00
    Deferred Charges 3.00 M 11.41 M 10.60 M 5.83 M 0.00
    Tangible Other Assets 0.00 0.00 0.00 0.00 0.00
    Intangible Other Assets 0.00 0.00 290,694.00 187,635.00 248,586.00
    Total Assets 84.69 M 142.72 M 68.49 M 99.25 M 32.47 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 0.00 0.00 0.00 0.00
    Accrued Payroll 794,375.00 824,143.00 641,474.00 873,786.00 299,955.00
    Income Taxes Payable 0.00 0.00 0.00 0.00 0.00
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 11.05 M 7.52 M 4.21 M 1.69 M 563,961.00
    Current Liabilities Total 17.11 M 28.12 M 10.73 M 11.38 M 2.83 M
    Long Term Debt 0.00 0.00 0.00 0.00 0.00
    Provision for Risks & Charges
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 20.94 M 49.69 M 36.60 M 29.43 M 300,000.00
    Deferred Tax Liability in Untaxed Reserves
    Other Liabilities 220,000.00 0.00 0.00 0.00 0.00
    Total Liabilities 38.27 M 77.81 M 47.33 M 40.81 M 3.13 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 46.43 M 64.91 M 21.16 M 58.44 M 29.33 M
    Common Stock 382,751.00 379,672.00 292,488.00 288,135.00 217,583.00
    Capital Surplus 295.21 M 288.68 M 216.31 M 210.01 M 154.88 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves
    Unappropriated (Free) Reserves
    Retained Earnings -249.27 M -224.54 M -195.48 M -151.86 M -125.76 M
    Equity in Untaxed Reserves
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 0.00 0.00
    Unrealized Gain (Loss) on Marketable Securities 103,507.00 378,057.00 32,463.00 0.00 0.00
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 84.69 M 142.72 M 68.49 M 99.25 M 32.47 M
    Common Shares Outstanding 38.28 M 37.97 M 29.25 M 28.81 M 21.76 M